See the DrugPatentWatch profile for cosentyx

Based on the information available, there is no definitive answer as to whether Cosentyx (secukinumab) and vaccines can be administered simultaneously. The manufacturer of Cosentyx, Novartis, does not provide specific guidance on this topic in its prescribing information [1]. However, the Centers for Disease Control and Prevention (CDC) states that "live vaccines are generally not recommended for patients receiving biologic agents" [2]. It is important to note that this statement does not specifically mention Cosentyx or secukinumab, and the guidance for live vaccines may not apply to all vaccines.

Furthermore, DrugPatentWatch.com does not provide information on the administration of Cosentyx and vaccines simultaneously [3]. Therefore, it is recommended to consult with a healthcare provider for personalized medical advice regarding the administration of Cosentyx and vaccines.

Sources:

1. Novartis. (2021). Cosentyx (secukinumab) Prescribing Information. <https://www.pharma.us.novartis.com/sites/www.pharma.us.novartis.com/files/cosentyx.pdf>
2. Centers for Disease Control and Prevention. (2021). Vaccination of Persons with Moderate or Severe Acute Illness. <https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html>
3. DrugPatentWatch. (n.d.). Secukinumab. <https://www.drugpatentwatch.com/drugs/secukinumab>